The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is ...
Wall Street is on edge after Friday's sharp reversal ahead of a week defined by Trump's Fed pick, jobs data and more Big Tech ...
Before Friday's selloff, gold and silver had been on a blistering yearlong rally, fueled by heavy central bank buying and ...
French drugmaker Sanofi said on Monday that its experimental genetic disorder treatment showed promise in a late-stage study of patients with a type of Gaucher disease, but failed to meet the main ...
By Christian Kraemer and Anna Wlodarczak-Semczuk WARSAW, Feb 2 (Reuters) - Germany and Poland must take joint responsibility ...
Japan said Monday it has successfully drilled and retrieved deep-sea sediment containing rare earth minerals from the seabed ...
Nvidia still reigns, but a structural shift toward custom silicon is creating a new hierarchy of winners and laggards, and ...
Wall Street is on edge after Friday's sharp reversal ahead of a week defined by Trump's Fed pick, jobs data and more Big Tech ...
Disney posted a strong first quarter, powered by box-office hits “Zootopia 2” and “Avatar: Fire and Ash. The Walt Disney Co.
LONDON, Feb 2 () - By Marc Jones, Global Markets Correspondent What matters in U. and global markets today The slump in gold, ...
Medical equipment maker Revvity handily beat fourth-quarter estimates and forecast 2026 revenue and profit above Wall Street ...
The U.S. Food and Drug administration has declined to approve Aquestive Therapeutics' oral drug for severe allergic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results